Brief: Nasdaq Grants Windtree Therapeutics 180-Day Extension To Regain Compliance
05/12/2022 12:52
Dec 5 (Reuters) - Windtree Therapeutics Inc WINT.O :
* NASDAQ GRANTS WINDTREE THERAPEUTICS 180-DAY EXTENSION TO
REGAIN
COMPLIANCE
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study